Nifty
Sensex
:
:
10452.30
34010.76
-93.20 (-0.88%)
-286.71 (-0.84%)

Miscellaneous

Rating :
73/99

BSE: 539787 | NSE: HCG

322.45
-7.75 (-2.35%)
16-Feb-2018 | 3:54PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 333.25
  • 333.50
  • 322.00
  • 330.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 41837
  • 134.90
  • 353.80
  • 215.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,866.98
  • 115.46
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,201.96
  • N/A
  • 6.15

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 24.38%
  • 7.91%
  • 10.42%
  • FII
  • DII
  • Others
  • 0.01%
  • 28.12%
  • 29.16%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Net Sales
206.25
176.15
17.09%
211.07
173.98
21.32%
191.10
167.55
14.06%
182.43
153.75
18.65%
Expenses
180.19
150.15
20.01%
180.00
148.58
21.15%
161.60
143.92
12.28%
152.46
127.79
19.31%
EBITDA
26.06
26.00
0.23%
31.07
25.40
22.32%
29.50
23.63
24.84%
29.97
25.96
15.45%
EBIDTM
12.64%
14.76%
14.72%
14.60%
15.44%
14.10%
16.43%
16.88%
Other Income
5.87
1.70
245.29%
1.90
2.36
-19.49%
2.42
2.03
19.21%
3.58
0.67
434.33%
Interest
10.39
5.11
103.33%
10.45
5.76
81.42%
6.96
5.22
33.33%
6.91
10.60
-34.81%
Depreciation
18.24
14.91
22.33%
16.70
14.39
16.05%
15.24
12.56
21.34%
14.98
11.72
27.82%
PBT
3.31
7.68
-56.90%
12.22
7.61
60.58%
9.72
7.88
23.35%
11.66
3.29
254.41%
Tax
2.30
2.64
-12.88%
2.01
2.71
-25.83%
3.64
2.87
26.83%
3.57
-1.53
-
PAT
1.01
5.04
-79.96%
10.21
4.90
108.37%
6.08
5.01
21.36%
8.09
4.82
67.84%
PATM
0.49%
2.86%
4.84%
2.82%
3.18%
2.99%
4.43%
3.13%
EPS
0.37
0.63
-41.27%
1.17
0.58
101.72%
0.55
0.59
-6.78%
0.81
0.43
88.37%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
790.85
700.11
584.17
519.38
450.07
345.34
269.89
217.75
Net Sales Growth
17.79%
19.85%
12.47%
15.40%
30.33%
27.96%
23.94%
 
Cost Of Goods Sold
186.40
170.91
150.02
146.03
133.41
103.50
81.37
63.47
Gross Profit
604.45
529.20
434.15
373.34
316.67
241.84
188.52
154.28
GP Margin
76.43%
75.59%
74.32%
71.88%
70.36%
70.03%
69.85%
70.85%
Total Expenditure
674.25
595.12
499.41
443.14
413.09
293.42
226.65
178.78
Power & Fuel Cost
-
16.42
14.35
13.29
11.69
9.38
6.89
5.48
% Of Sales
-
2.35%
2.46%
2.56%
2.60%
2.72%
2.55%
2.52%
Employee Cost
-
121.92
100.53
81.51
78.24
54.24
42.83
32.76
% Of Sales
-
17.41%
17.21%
15.69%
17.38%
15.71%
15.87%
15.04%
Manufacturing Exp.
-
36.63
31.47
30.26
11.88
9.34
6.45
4.92
% Of Sales
-
5.23%
5.39%
5.83%
2.64%
2.70%
2.39%
2.26%
General & Admin Exp.
-
230.94
186.02
152.59
40.89
22.95
17.22
18.24
% Of Sales
-
32.99%
31.84%
29.38%
9.09%
6.65%
6.38%
8.38%
Selling & Distn. Exp.
-
10.51
9.56
13.94
0.00
0.00
5.31
4.08
% Of Sales
-
1.50%
1.64%
2.68%
0%
0%
1.97%
1.87%
Miscellaneous Exp.
-
7.78
7.46
5.50
136.97
94.01
66.59
49.84
% Of Sales
-
1.11%
1.28%
1.06%
30.43%
27.22%
24.67%
22.89%
EBITDA
116.60
104.99
84.76
76.24
36.98
51.92
43.24
38.97
EBITDA Margin
14.74%
15.00%
14.51%
14.68%
8.22%
15.03%
16.02%
17.90%
Other Income
13.77
9.67
3.99
4.81
5.23
2.58
3.88
1.37
Interest
34.71
23.00
38.33
34.23
32.23
29.18
23.98
13.61
Depreciation
65.16
56.83
44.08
39.25
36.28
30.05
23.77
17.61
PBT
36.91
34.84
6.34
7.58
-26.29
-4.73
-0.63
9.12
Tax
11.52
11.80
-1.97
-1.68
5.35
0.71
0.23
0.98
Tax Rate
31.21%
33.87%
-729.63%
-55.63%
-14.75%
-15.01%
-36.51%
10.75%
PAT
25.39
22.17
-1.46
0.84
-43.70
-6.10
-1.64
7.40
PAT before Minority Interest
25.03
23.04
2.24
4.70
-41.62
-5.45
-0.85
8.14
Minority Interest
-0.36
-0.87
-3.70
-3.86
-2.08
-0.65
-0.79
-0.74
PAT Margin
3.21%
3.17%
-0.25%
0.16%
-9.71%
-1.77%
-0.61%
3.40%
PAT Growth
28.43%
1618.49%
-273.81%
101.92%
-616.39%
-271.95%
-122.16%
 
Unadjusted EPS
2.90
2.69
-2.43
0.12
-0.30
1.02
-0.28
1.38

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
432.66
425.82
279.49
263.48
292.04
214.59
172.42
Share Capital
85.71
85.08
69.98
68.25
66.89
59.27
53.30
Total Reserves
345.73
339.84
205.22
192.42
223.80
154.42
111.32
Non-Current Liabilities
351.01
305.83
278.51
256.91
255.98
148.18
96.32
Secured Loans
136.79
80.34
171.24
240.50
228.01
129.45
89.57
Unsecured Loans
146.59
165.49
109.00
11.30
11.33
5.95
4.15
Long Term Provisions
3.05
2.90
2.26
2.19
3.23
2.39
3.05
Current Liabilities
368.60
262.83
187.00
149.18
155.88
136.77
88.31
Trade Payables
141.04
108.42
83.27
70.53
52.72
36.28
36.17
Other Current Liabilities
179.60
113.41
70.99
58.02
64.71
47.77
30.37
Short Term Borrowings
41.63
37.18
29.27
18.00
38.02
51.72
21.57
Short Term Provisions
6.33
3.81
3.47
2.63
0.44
1.00
0.20
Total Liabilities
1,209.73
1,027.17
770.30
687.59
720.77
508.03
362.45
Net Block
684.70
582.96
528.50
510.94
505.64
377.60
263.42
Gross Block
773.36
620.21
719.54
661.24
620.68
461.03
323.08
Accumulated Depreciation
88.66
37.25
191.05
150.29
115.04
83.43
59.66
Non Current Assets
965.55
799.82
648.32
578.46
556.76
420.56
310.78
Capital Work in Progress
148.23
120.86
42.24
10.87
6.27
14.69
3.73
Non Current Investment
3.95
3.63
0.12
2.33
0.12
0.12
0.12
Long Term Loans & Adv.
82.24
66.62
67.56
47.51
37.62
24.90
41.58
Other Non Current Assets
46.44
25.75
9.90
6.81
7.10
3.26
1.94
Current Assets
244.18
227.35
121.97
109.13
164.01
87.47
51.67
Current Investments
7.49
60.02
0.00
0.00
60.37
0.09
0.83
Inventories
18.77
13.35
14.55
11.98
9.97
7.07
5.32
Sundry Debtors
103.22
69.54
63.81
52.06
62.81
43.59
29.13
Cash & Bank
85.22
57.61
26.95
25.48
10.67
16.63
5.75
Other Current Assets
29.48
4.05
12.14
9.56
20.18
20.10
10.63
Short Term Loans & Adv.
25.05
22.77
4.52
10.05
5.15
8.41
2.72
Net Current Assets
-124.43
-35.47
-65.02
-40.05
8.13
-49.30
-36.65
Total Assets
1,209.73
1,027.17
770.29
687.59
720.77
508.03
362.45

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
73.20
59.65
49.64
28.56
17.62
33.24
PBT
0.27
3.01
-36.26
-4.73
-0.63
9.12
Adjustment
85.70
73.34
90.72
60.12
44.22
31.25
Changes in Working Capital
-1.91
-10.17
3.94
-19.27
-22.64
-2.38
Cash after chg. in Working capital
84.07
66.18
58.40
36.12
20.96
38.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-10.87
-6.53
-8.76
-7.56
-5.01
-4.76
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
1.67
0.00
Cash From Investing Activity
-203.57
-79.71
-57.70
-99.88
-39.17
-31.25
Net Fixed Assets
-73.66
-91.33
-74.79
-73.44
-99.83
Net Investments
-70.89
-3.75
72.52
-121.14
-1.48
Others
-59.02
15.37
-55.43
94.70
62.14
Cash from Financing Activity
215.59
21.56
22.87
65.61
32.42
-0.52
Net Cash Inflow / Outflow
85.22
1.51
14.81
-5.71
10.87
1.47
Opening Cash & Equivalents
-4.52
22.30
10.67
16.38
5.75
4.29
Closing Cash & Equivalent
80.45
24.75
25.48
10.67
16.63
5.75

Financial Ratios

Standalone /

Consolidated
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
50.34
49.95
39.32
38.19
43.46
36.05
30.88
ROA
2.06%
0.25%
0.64%
-5.91%
-0.76%
-0.20%
2.25%
ROE
5.38%
0.64%
1.75%
-15.10%
-1.87%
-0.45%
4.95%
ROCE
7.22%
5.60%
6.41%
-0.73%
4.29%
6.33%
7.42%
Fixed Asset Turnover
1.00
0.87
0.75
0.70
0.56
0.69
0.67
Receivable days
45.03
41.66
40.71
46.58
66.39
49.17
48.82
Inventory Days
8.37
8.72
9.32
8.90
10.54
8.38
8.92
Payable days
108.59
99.93
85.50
82.06
91.96
78.37
100.96
Cash Conversion Cycle
-55.19
-49.55
-35.46
-26.57
-15.03
-20.83
-43.22
Total Debt/Equity
0.97
0.76
1.27
1.04
0.95
1.01
0.81
Interest Cover
2.52
1.01
1.09
-0.13
0.84
0.97
1.67

News Update:


  • HCG executes LLP Agreement with Shiv-Sun
    17th Feb 2018, 10:02 AM

    The Capital contribution of HCG and Shiv-Sun in the LLP shall be in the ratio of 74% and 26%

    Read More
  • Quadria Capital makes investment in HCG’s Strand Life Sciences
    12th Feb 2018, 14:41 PM

    The investment by Quadria will fund the strategic expansion of Strand and the build out of a unique integrated platform dedicated to next generation precision medicine

    Read More
  • HCG completes transaction under BTA, SSA with Strand Life Sciences
    10th Feb 2018, 09:49 AM

    The shareholding of the company in Strand Life Sciences stands at 38.2% on a fully diluted basis

    Read More
  • HealthcareGlobal - Quarterly Results
    8th Feb 2018, 16:40 PM

    Read More
  • HCG executes definitive agreements for business combination of Triesta with Strand
    5th Jan 2018, 09:22 AM

    The combination of Triesta and Strand creates an integrated platform with end to end capabilities in precision medicine

    Read More
  • HCG inks agreement to acquire 48.5% shareholding in Strand Life Sciences
    4th Jan 2018, 08:49 AM

    It has entered into definitive agreements providing for a business combination of its Triesta Sciences business unit with Strand Life Sciences

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.